Cinevista closes trading window from October 1 for Q2FY27 results
- Trading window closed from October 1, 2026
- Restriction applies to designated employees and relatives
- Window reopens 48 hours after Q2FY27 results announcement
- Compliance with SEBI insider trading regulations cited

*this image is generated using AI for illustrative purposes only.
Cinevista Limited has closed its trading window for designated employees and their immediate relatives starting October 1, 2026. This restriction is in place ahead of the company's announcement of un-audited or audited financial results for the quarter ended September 30, 2026.
The closure is implemented in compliance with SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, and the company's internal Insider Trading Code. It also adheres to circulars issued by BSE Limited (LIST/CAMP/01/2019-20) and the National Stock Exchange of India Ltd. (NSE/CML/2019/11), both dated April 2, 2019.
Trading window reopening timeline
The trading window will reopen 48 hours after the company announces its financial results to the stock exchanges. This standard procedure ensures that insider information regarding the quarterly performance is not used for trading purposes before it becomes public knowledge.
| Event | Date |
|---|---|
| Trading window closure | October 1, 2026 |
| Reporting period | Quarter ended September 30, 2026 |
| Window reopening | 48 hours after results announcement |
The notice was signed by Kilpa Goradia, Company Secretary, and addressed to the Corporate Service Department of BSE and the National Stock Exchange. Cinevista maintains its registered office in Bandra West, Mumbai.
Historical Stock Returns for Cinevista
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.62% | +1.97% | +2.11% | -4.79% | -23.23% | +9.51% |
How might Cinevista's Q2 FY27 financial results influence its stock price volatility once the trading window reopens?
What specific operational or revenue drivers are analysts expecting to see in Cinevista's upcoming quarterly report?
Are there any pending regulatory reviews or corporate actions that could coincide with the announcement of these financial results?


































